DuPont de Nemours Inc vs IDEXX Laboratories, Inc. — how do they compare? DuPont de Nemours Inc trades at $144.26 (market cap $19.51B), while IDEXX Laboratories, Inc. trades at $587.21 (market cap $46.22B). The key difference: IDEXX Laboratories, Inc. is far larger — about 2.4× DuPont de Nemours Inc's market cap, and DuPont de Nemours Inc pays a 1.66% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| DD | IDXX | |
|---|---|---|
Market Cap | $19.51B | $46.22B |
Sector | Basic Materials | Health |
52-Week High | $154.59 | $766.68 |
52-Week Low | $90.24 | $526.44 |
Enterprise Value | $20.90B | $47.12B |
Dividend Yield | 1.66% | — |
Trailing returns across standard periods
Latest headlines on both assets
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.
Read more on DD →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →